Latest Articles
Organon Ends Development of OG-6219 After Endometriosis Trial Fails to Meet Primary Endpoint - MarketScreener
Organon Ends Development of OG-6219 After Endometriosis Trial Fails to Meet Primary Endpoint MarketScreener
Published: July 2, 2025, 12:10 p.m.
Organon halts development of endometriosis pain drug after trial failure By Investing.com - Investing.com Canada
Organon halts development of endometriosis pain drug after trial failure By Investing.com Investing.com Canada
Published: July 2, 2025, 12:08 p.m.
Organon ELENA trial misses primary endpoint, to discontinue OG-6219 program - TipRanks
Organon ELENA trial misses primary endpoint, to discontinue OG-6219 program TipRanks
Published: July 2, 2025, 11:54 a.m.
Organon to halt development of endometriosis pain drug after mid-stage trial failure - MarketScreener
Organon to halt development of endometriosis pain drug after mid-stage trial failure MarketScreener
Published: July 2, 2025, 11:52 a.m.
Organon abandons endometriosis pain drug development after trial failure - MarketScreener
Organon abandons endometriosis pain drug development after trial failure MarketScreener
Published: July 2, 2025, 11:52 a.m.
Organon halts development of endometriosis pain drug after trial failure - Investing.com
Organon halts development of endometriosis pain drug after trial failure Investing.com
Published: July 2, 2025, 11:42 a.m.
Endometriosis linked to four-times higher pregnancy rates than other causes of infertility, study reveals - Medical Xpress
Endometriosis linked to four-times higher pregnancy rates than other causes of infertility, study reveals Medical Xpress
Published: July 2, 2025, 11:33 a.m.
Sun Pharma Gets CDSCO Panel Go-Ahead to Manufacture, Market Relugolix, Estradiol, Norethindrone Acetate... - Medical Dialogues
Sun Pharma Gets CDSCO Panel Go-Ahead to Manufacture, Market Relugolix, Estradiol, Norethindrone Acetate... Medical Dialogues
Published: July 2, 2025, 11:31 a.m.
Organon's Promising Endometriosis Drug OG-6219 Falls Short in Critical Phase 2 Trial, Program Discontinued - Stock Titan
Organon's Promising Endometriosis Drug OG-6219 Falls Short in Critical Phase 2 Trial, Program Discontinued Stock Titan
Published: July 2, 2025, 11:30 a.m.
Doctor shares 6 causes of painful periods after pregnancy and how to reduce pain | Health - Hindustan Times - Hindustan Times
Doctor shares 6 causes of painful periods after pregnancy and how to reduce pain | Health - Hindustan Times Hindustan Times
Published: July 2, 2025, 8:39 a.m.
Link copied to clipboard!